Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938466 · ClinicalTrials.gov registry record
Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 19
- Enrollment target
NCT04938466 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 19 participants.
The verdict
NCT04938466 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of the study is to compare quality of life, adherence, insulin resistance, body composition and efficacy of long-acting growth hormone (LAGH) to daily growth hormone (DGH) in children with growth hormone deficiency (GHD). These objectives will be evaluated every 6 months for subjects prior to switch from DGH to LAGH, and 6 months after.
Interventions
- DRUG Long-Acting Growth Hormone (LAGH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2024-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04938466
The ClinicalTrials.gov registry entry for NCT04938466 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Long-Acting Growth Hormone (LAGH) is the first listed.
NCT04938466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04938466 about?
NCT04938466 is a clinical study titled "Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy". The purpose of the study is to compare quality of life, adherence, insulin resistance, body composition and efficacy of long-acting growth hormone (LAGH) to daily growth hormone (DGH) in children with growth hormone deficiency (GHD). These objectives will be evaluated every 6 months for subjects pri...
What is the current status of trial NCT04938466?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2021-08-05. Estimated completion is 2024-10-30.
What interventions are being tested in trial NCT04938466?
The interventions under investigation include: Long-Acting Growth Hormone (LAGH) (DRUG).
Who is sponsoring clinical trial NCT04938466?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.